SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-050626
Filing Date
2024-04-23
Accepted
2024-04-23 16:41:28
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-23

Document Format Files

Seq Description Document Type Size
1 ARS tm242724d3ars.pdf ARS 2315210
  Complete submission text file 0001104659-24-050626.txt   3173479
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38492 | Film No.: 24865370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)